ROR1 and B-cell chronic lymphocytic leukemia: Preclinical data demonstrated that CAR-T cells can accurately recognize autologous ROR1-expressing tumor cells or cell lines and could serve as a powerful weapon to eliminate chemotherapy resistant CLL cells.